Vu V.

Design of Potent, Orally Available Antagonists of the Transient Receptor Potential Vanilloid 1. Structure−Activity Relationships of 2-Piperazin-1-yl-1<i>H</i>-benzimidazoles

Vassil I. Ognyanov, Balan Chenera, Anthony W. Bannon et al. · Journal of Medicinal Chemistry · 2006 · 83 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of TRPM8 Antagonist (<i>S</i>)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid (AMG 333), a Clinical Candidate for the Treatment of Migraine

Daniel B. Horne, Kaustav Biswas, James Brown et al. · Journal of Medicinal Chemistry · 2018 · 61 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Optimization of Potency and Pharmacokinetic Properties of Tetrahydroisoquinoline Transient Receptor Potential Melastatin 8 (TRPM8) Antagonists

Daniel B. Horne, Nuria Tamayo, Michael D. Bartberger et al. · Journal of Medicinal Chemistry · 2014 · 42 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Structure–activity relationship (SAR) investigations of tetrahydroquinolines as BKCa agonists

Vijay Gore, Vu V., Ruoyuan Yin et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 39 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Structure–activity relationship (SAR) investigations of substituted imidazole analogs as TRPV1 antagonists

Vijay Gore, Vu V., Rami Tamir et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16